As a Market Access and Pricing Expert in the pharmaceutical industry, she specializes in pricing, reimbursement, and market access strategies across both U.S. and European healthcare systems. She has a strong background in Medicare/ Medicaid, private payers, and ICER in the U.S., as well as HTA submissions (e.g., NICE, HAS) and pricing negotiations in Europe. Her expertise spans health economics, value-based pricing models, and global market access, including cost-effectiveness analysis, real-world evidence generation, and payer engagement. She has experience of working with cross-functional teams to navigate complex payer landscapes, secure formulary access, and deliver compelling value propositions that balance patient access with business goals. Key Areas of Expertise:
U.S. & EU Pharma Pricing & Reimbursement (Medicare/Medicaid, ICER, NICE, HAS)
Global Market Access Strategy
Health Economics & Outcomes Research (HEOR)
HTA Submissions & Payer Engagement
Value-Based Pricing & Bio-similars
